Portugal’s Hope Care Raises €6M to Expand Remote Patient Monitoring
Portuguese digital health company Hope Care has raised €6 million in a Series A round led by Iberis Capital to expand its remote patient monitoring technology across Europe. Vieira de Matos – VDM Capital and existing investor Buenavista Equity Partners also participated in the round, which consists entirely of new capital.
Founded in 2012, Hope Care develops OpMA, a regulated platform that combines data from medical devices, information reported by patients and clinical workflows. The company plans to use the funding to strengthen its commercial and operational teams and accelerate the rollout of remote monitoring programmes in key European healthcare markets.
Hope Care Expands Beyond Portugal
Hope Care already operates remote patient monitoring programmes in Portugal and France and has a project underway in Switzerland. It has also established Hope Care GmbH in Erlangen, Germany, where its first deployment is scheduled to begin in October 2026.
The company is also preparing to establish a presence in Romania, with initial setup activities expected to begin by the end of September. The expansion gives Hope Care a wider European base as healthcare providers increasingly look for ways to monitor patients outside hospitals and respond to chronic conditions earlier.
Platform Covers Chronic Care Programmes
OpMA is designed to bring different types of patient information into a single system so healthcare organisations can manage remote care programmes. Medical device readings, patient-reported outcomes and clinical workflows can be combined within the platform.
In Portugal, Hope Care says its technology is used across 15 Local Health Units, covering about 45% of people registered with the country's National Health Service. Its platform is also used by the regional health services of Madeira and the Azores, as well as private healthcare providers, social care organisations and municipalities.
Clinical Results Support Expansion
Hope Care says its remote monitoring programmes have already produced measurable results. In a 12-month analysis involving 43 people with chronic obstructive pulmonary disease, one programme was associated with a 76% reduction in hospital days and a 74% reduction in emergency department visits.
The company estimated annual savings of €4,811 per patient in that programme. The figures come from a relatively small patient group and are company-reported, but they provide part of the evidence Hope Care is using as it seeks to expand within public healthcare systems.
Sales Growth Adds Momentum
The funding follows a strong period of commercial growth for Hope Care. The company reported that sales in the first half of 2026 were 2.5 times higher than during the same period in 2025.
The growth comes as European healthcare systems face increasing pressure from chronic diseases and limited clinical capacity. Remote monitoring can allow healthcare providers to track patients from home and intervene when health indicators change, potentially reducing the need for some hospital visits.
€6M Round Targets European Scale
For Hope Care, the new funding is primarily about taking an established platform into additional healthcare markets rather than developing an early-stage product from scratch. The company has spent more than a decade working with healthcare institutions and is now using its existing deployments as a foundation for international expansion.
Its immediate focus is Germany and Romania, while operations in Portugal, France and Switzerland continue to grow. If the new deployments achieve similar adoption, Hope Care will have a broader European footprint for its regulated remote patient monitoring technology.
